Adamis Pharma (ADMP)

NASDAQ
0.7453
+0.0081(+1.10%)
After Hours
0.755
+0.0097(+1.3015%)
- Real-time Data
  • Volume:
    11,659,991
  • Bid/Ask:
    0.7489/0.755
  • Day's Range:
    0.74 - 0.8333

ADMP Overview

Prev. Close
0.7372
Day's Range
0.74 - 0.8333
Revenue
16.53M
Open
0.7428
52 wk Range
0.382 - 2.34
EPS
-0.62
Volume
11,659,991
Market Cap
110.96M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
7,372,909
P/E Ratio
-
Beta
1.32
1-Year Change
47.67%
Shares Outstanding
148,886,141
Next Earnings Date
May 07, 2021
What is your sentiment on Adamis Pharma?
or
Market is currently closed. Voting is open during market hours.

Adamis Pharma News

Adamis Pharma Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellSellSell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Adamis Pharma Company Profile

Adamis Pharma Company Profile

Employees
116

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Read More
  • finally a buy
    0
    • #ETORO is a all time cheater! today whole day not able to access any stocks buy or sell.  Disappointing Platform..
      2
      • Me too im just sick
        0
    • Unbelievable...totally no sense.
      0
      • what happen to this counter pre-market drop more than 20%!!!
        0
        • ETORO DOWN AGAIN !!!!!!
          0
          • Together bro
            0
          • Hey guys, etoro down again :( have u tried this broker? (investing.com)seems weirdly interesting
            0
          • Hey guys, etoro down again :( have u tried this broker? (investing.com)seems weirdly interesting
            0
        • seriously  ETORO ******
          0
          • Good thing come to people who wait fda last date to approve 22/2
            0
            • what's going on with the stock?
              0
              • what's going on?
                0
                • #ETORO got technical problem as usual, not able to buy or sell any stocks
                  0
                  • lets push admp to the moon
                    2
                    • 1 more week before good news or bad news for zimhi and Tempol, any thoughts?
                      0
                      • how come the fda calender not show anything regarding admp on 20 Feb 2021?
                        0
                      • how come the fda calender not show anything regarding admp ?
                        0
                    • if admp get to 2.50 I'm jumping out cause I honestly don't know why it back green but I was holding so by all means raise raiseeeee
                      2
                      • have a look also at Botanix Pharmaceuticals (BOT). Probably a good time to get in! ✊🏻
                        0
                        • https://industrytoday.co.uk/pharmaceutical/epinephrine-market-worth-us--4-207-88-mn-in-2027---kaleo--adamis-pharmaceuticals--emirade
                          1
                          • https://www.google.es/amp/s/www.business-newsupdate.com/epinephrine-auto-injector-industry-market-13673/amp
                            1
                            • So.... Buy the dip or let die this poor dogo ?
                              1
                              • Buy close to 1.02. It shud gain a 20% this week post the close of offering, which is tomorrow.
                                0
                            • Anybody knows how long before FDA reviews tempol? Thanks
                              1
                              • Phase 2/3 clinical trial is listed at ClinicalTrials.gov. 60 COVID-19+ subjects will be treated. Estimated start date April 1, 2021. https://clinicaltrials.gov/ct2/show/NCT04729595
                                0
                              • Ralf Adams  Thanks, now buy or wait?
                                0
                              • Ralf AdamsThank you! If the medicine is effective they must approve it right? Or if theres more applications they select a few? 🙏🏼
                                0
                            • pump and dump...COCG/TRXC definitely better choices... ADMP has very poor financial cash results
                              4
                              • which ones is COCG? i cannt find it in investing
                                0
                            • Come on rise
                              0
                              • 1.5
                                0
                                • Not going to trade this PM, looking for a  2.10 -2.15 open or even for an open above  2.40,  will get in with an initial price target of 3.20. Open below 2.10ish and going long becomes risky
                                  1
                                  • Do you think this stock will move up next week?
                                    0
                                • it is still not too late, it will run more after the market opens
                                  1
                                  • it is still not too late, it will run more after the market opens
                                    3
                                    • price target 🎯 ? 5-6?
                                      3
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.